Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma
Authors:
- 1 November 2010
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 80 (10) , 1517-1527
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Lotta al Neuroblastoma
This publication has 56 references indexed in Scilit:
- Targeting the hypoxia-inducible factor (HIF) pathway in cancerExpert Reviews in Molecular Medicine, 2009
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer CellsJournal of Biological Chemistry, 2008
- The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species productionJournal of Cell Biology, 2007
- Cell-Permeating α-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient CellsMolecular and Cellular Biology, 2007
- Metabolic catastrophe as a means to cancer cell deathJournal of Cell Science, 2007
- The Mitochondrial Production of Reactive Oxygen Species: Mechanisms and Implications in Human PathologyIUBMB Life, 2001